AMGN Financial Facts
Total operating expenses: 2.8BInterest expense, net: 263M
See Full Income Statement
Trade receivables, net: 2.53B
Total current assets: 28.7B
See Full Balance Sheet
Earnings History for Amgen Inc. (AMGN)
|
Expand Research on AMGN
| Next EPS Date | 7/25/13 *Est. | EPS Growth Rate | +21.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +9.9% | Revenue Growth Rate | +3.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.9% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1/26/12 |
Q411 | $1.21 | $1.22 | -$0.01 | $3.97B | $3.91B | $1.26 / $4B | ![]() |
+54.9% | Details | |
| 1/23/13 |
Q412 | $1.40 | $1.39 | +$0.01 | $4.42B | $4.37B | N/A / N/A | = | +26.4% | Details | |
| 4/20/11 |
Q111 | $1.34 | $1.29 | +$0.05 | $3.7B | $3.68B | N/A / N/A | = | +88% | Details | |
| 1/24/11 | Q410 | $1.17 | $1.10 | +$0.07 | $3.84B | $3.8B | N/A / N/A | = | +84.7% | Details | |
| 4/23/13 |
Q113 | $1.96 | $1.84 | +$0.12 | $4.2B | $4.37B | N/A / N/A | = | -6.5% | Details | |
| 7/29/11 |
Q211 | $1.37 | $1.28 | +$0.09 | $3.96B | $3.78B | N/A / N/A | = | +97.7% | Details | |
| 10/25/10 |
Q310 | $1.36 | $1.27 | +$0.09 | N/A | N/A | N/A / N/A | = | +82.3% | Details | |
| 10/24/11 |
Q311 | $1.40 | $1.30 | +$0.10 | $3.94B | $3.87B | N/A / N/A | = | +79.1% | Details |

